-
公开(公告)号:US09737552B2
公开(公告)日:2017-08-22
申请号:US13994514
申请日:2011-12-14
申请人: Adam Kaplin , Barbara S. Slusher , Kristen A. Rahn
发明人: Adam Kaplin , Barbara S. Slusher , Kristen A. Rahn
IPC分类号: A61K31/662 , A61K49/06 , A61K31/19 , A61K31/66
CPC分类号: A61K31/662 , A61K31/19 , A61K31/66 , A61K49/06
摘要: Described herein are methods for the treatment of cognitive impairment in a subject with a neurological autoimmune disease and methods for determining whether a subject who has a central nervous system autoimmune disease is likely to acquire a cognitive impairment.
-
2.TREATMENT OF COGNITIVE IMPAIRMENT IN A SUBJECT WITH A NEUROLOGICAL AUTOIMMUNE DISEASE 有权
标题翻译: 治疗神经性自发性疾病患者的认知功能障碍公开(公告)号:US20130344000A1
公开(公告)日:2013-12-26
申请号:US13994514
申请日:2011-12-14
申请人: Adam Kaplin , Barbara S. Slusher , Kristen A. Rahn
发明人: Adam Kaplin , Barbara S. Slusher , Kristen A. Rahn
IPC分类号: A61K31/662 , A61K49/06
CPC分类号: A61K31/662 , A61K31/19 , A61K31/66 , A61K49/06
摘要: Described herein are methods for the treatment of cognitive impairment in a subject with a neurological autoimmune disease and methods for determining whether a subject who has a central nervous system autoimmune disease is likely to acquire a cognitive impairment.
摘要翻译: 本文描述了用于治疗患有神经系统自身免疫疾病的受试者的认知障碍的方法和用于确定具有中枢神经系统自身免疫疾病的受试者是否可能获得认知障碍的方法。
-
3.USE OF HIGH-DOSE OXAZAPHOSPHORINE DRUGS IN COMBINATION WITH MONOCLONAL ANTIBODIES FOR TREATING IMMUNE DISORDERS 审中-公开
标题翻译: 用于治疗免疫缺陷病毒的单克隆抗体联合使用高剂量氧杂萘酚药物公开(公告)号:US20120128685A1
公开(公告)日:2012-05-24
申请号:US13240465
申请日:2011-09-22
申请人: Robert A. Brodsky , Richard J. Jones , Francis E. O'Donnell, JR. , Susan Bonitz , Carlos Santos , Adam Kaplin
发明人: Robert A. Brodsky , Richard J. Jones , Francis E. O'Donnell, JR. , Susan Bonitz , Carlos Santos , Adam Kaplin
IPC分类号: A61K39/395 , A61P37/00
CPC分类号: A61K31/664 , A61K39/39541 , Y02A50/401 , A61K2300/00
摘要: The present invention relates to methods of treating an autoimmune disorder, using a lymphocytotoxic but hematopoeitic cell sparing high-dose pulsed amount of an oxazaphosphorine drug in combination with immune therapeutics such as, for example, monoclonal antibodies that selectively bind B-cell specific antigens.
摘要翻译: 本发明涉及使用淋巴细胞毒性但造血细胞治疗高剂量脉冲量的恶唑磷酸药物与免疫治疗剂例如选择性结合B细胞特异性抗原的单克隆抗体联合治疗自身免疫病症的方法。
-
4.METHODS AND COMPOSITIONS OF TREATING AND PREVENTING AUTOIMMUNE DISEASES 审中-公开
标题翻译: 治疗和预防自身免疫疾病的方法和组合公开(公告)号:US20110212052A1
公开(公告)日:2011-09-01
申请号:US13055880
申请日:2009-07-24
申请人: Adam Kaplin
发明人: Adam Kaplin
CPC分类号: A61K31/66 , A61K38/16 , A61K38/193 , A61K2300/00
摘要: Provided are methods and compositions for treating and/or preventing an autoimmune diseases, including inflammatory bowel disease, rheumatoid arthritis, diabetes mellitus, celiac disease, autoimmune thyroid disease, autoimmune liver disease, Addison's Disease, Sjögren's Syndrome, transplant rejection, graft vs. host disease, or host vs. graft disease.
摘要翻译: 提供用于治疗和/或预防自身免疫性疾病的方法和组合物,包括炎症性肠病,类风湿性关节炎,糖尿病,乳糜泻,自身免疫性甲状腺疾病,自身免疫性肝病,艾迪生病,Sjögren综合征,移植排斥反应,移植物抗宿主 疾病或宿主与移植物疾病。
-
5.Method of identifying patients not suitable for high-dose cyclophosphamide treatment 有权
标题翻译: 鉴定不适合高剂量环磷酰胺治疗的患者的方法公开(公告)号:US09279803B2
公开(公告)日:2016-03-08
申请号:US13240443
申请日:2011-09-22
申请人: Robert A. Brodsky , Richard J. Jones , Francis E. O'Donnell, Jr. , Susan Bonitz , Adam Kaplin , Carlos Santos
发明人: Robert A. Brodsky , Richard J. Jones , Francis E. O'Donnell, Jr. , Susan Bonitz , Adam Kaplin , Carlos Santos
CPC分类号: G01N33/5047 , C12Q1/32 , G01N33/94 , G01N33/9493 , Y02A50/57
摘要: The present invention provides methods of identifying subjects that are suitable and not suitable for high-dose cyclophosphamide treatment.
摘要翻译: 本发明提供了鉴定适合于并不适合高剂量环磷酰胺治疗的受试者的方法。
-
6.METHOD OF IDENTIFYING PATIENTS SUITABLE FOR HIGH-DOSE CYCLOPHOSPHAMIDE TREATMENT 有权
标题翻译: 识别适合高剂量环磷酰胺治疗的患者的方法公开(公告)号:US20120129206A1
公开(公告)日:2012-05-24
申请号:US13240443
申请日:2011-09-22
申请人: Robert A. Brodsky , Richard J. Jones , Francis E. O'Donnell, JR. , Susan Bonitz , Adam Kaplin , Carlos Santos
发明人: Robert A. Brodsky , Richard J. Jones , Francis E. O'Donnell, JR. , Susan Bonitz , Adam Kaplin , Carlos Santos
IPC分类号: C12Q1/32
CPC分类号: G01N33/5047 , C12Q1/32 , G01N33/94 , G01N33/9493 , Y02A50/57
摘要: The present invention provides methods of identifying subjects that are suitable for high-dose cyclophosphamide treatment.
摘要翻译: 本发明提供了鉴定适合于高剂量环磷酰胺治疗的受试者的方法。
-
-
-
-
-